ALXO ALX Oncology Holdings Inc. - Common Stock
$1,99
السعر · مايو 20, 2026
البيانات الأساسية اعتبارًا من مايو 8, 2026
نطاق 52 أسبوعًا
$0–$3
71% of range
تقييم المحللين
BUY
13 analysts
السعر المستهدف
$5
+131% upside
P/E (TTM)
-0.6
ROE
-225.0%
هامش صافي الربح
—
ALXO لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$1.99
القيمة السوقية
$61M
P/E (TTM)
-0.6
ربح السهم (آخر 12 شهرًا)
$-1.90
الإيرادات (آخر 12 شهرًا)
—
عائد التوزيعات
—
ROE
-225.0%
D/E الدين/حقوق الملكية
0.4
نطاق 52 أسبوعًا
$0 – $3
ALXO مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
—
2018-12-31
→
2022-12-31
ربح السهم
$-1.90
2020-12-31
→
2025-12-31
التدفق النقدي الحر
$-84M
2020-12-31
→
2025-12-31
الهوامش
—
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
ALXO
متوسط الأقران
P/E (TTM)
-0.6
9.4
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
16.5
20.8
P/B (السعر / القيمة الدفترية)
2.4
1.8
EV / EBITDA
-0.3
—
Price / FCF (السعر / التدفق النقدي الحر)
-0.7
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
ALXO
متوسط الأقران
ROA (العائد على الأصول)
-98.3%
-30.4%
ROE
-225.0%
-54.4%
ROIC
-291.1%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
ALXO
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
0.4
26.6
Current Ratio (النسبة الحالية)
2.1
3.8
Quick Ratio (النسبة السريعة)
1.8
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
ALXO
متوسط الأقران
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
ALXO
متوسط الأقران
ALXO توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
13 محللين
- شراء قوي 3 23,1%
- شراء 8 61,5%
- احتفاظ 2 15,4%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
5 محللين · 2026-05-18
الوسيط
$4.00
المتوسط
$4.60
← أقل من جميع الأهداف
$1.99
منخفض
$4.00
مرتفع
$6.00
السعر المستهدف الوسيط
$4.00
+101,0%
السعر المستهدف المتوسط
$4.60
+131,2%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
-0.01%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 31 مارس، 2026 | $-0.15 | $-0.20 | 0.05% |
| 31 ديسمبر، 2025 | $-0.37 | $-0.37 | -0.00% |
| 30 سبتمبر، 2025 | $-0.41 | $-0.37 | -0.04% |
| 30 يونيو، 2025 | $-0.43 | $-0.46 | 0.03% |
| 31 مارس، 2025 | $-0.58 | $-0.47 | -0.11% |
مقارنة النظراء المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| SABS | — | — | — | — | — | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| AVXL | $771M | -16.5 | -36.1% | -991.4% | -47.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $0 | $1M | $5M | |
| R&D Expense | $77M | $116M | $142M | $98M | $60M | $29M | $16M | |
| SG&A Expense | $24M | $26M | $28M | $29M | $23M | $15M | $3M | |
| Operating Expenses | $104M | $142M | $170M | $127M | $84M | $45M | $24M | |
| Operating Income | $-104M | $-142M | $-170M | $-127M | $-84M | $-44M | $-19M | |
| Interest Expense | $2M | $2M | $2M | $238.0K | $13.0K | · | · | |
| Interest Income | $4M | $9M | $11M | $4M | $91.0K | · | · | |
| Other Non-op | $-36.0K | $-20.0K | $389.0K | $-22.0K | $-7.0K | $-1M | $-5.0K | |
| Pretax Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-45M | $-19M | |
| Income Tax | $0 | $0 | $0 | $64.0K | $-21.0K | $241.0K | $34.0K | |
| Net Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | $-19M | |
| EPS (Basic) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| EPS (Diluted) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| Shares (Basic) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | 3,076,461 | |
| Shares (Diluted) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | · | |
| EBITDA | $-103M | $-142M | $-169M | $-127M | $-84M | $-43M | · |
الميزانية العمومية 23
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $18M | $22M | $49M | $364M | $434M | $9M | |
| Short-term Investments | $28M | $110M | $160M | $217M | · | · | · | |
| Prepaid Expense | $6M | $7M | $6M | $5M | $3M | $2M | $256.0K | |
| Other Current Assets | $20.0K | $27.0K | $439.0K | · | · | · | · | |
| Current Assets | $51M | $134M | $189M | $271M | $367M | $436M | $10M | |
| PP&E (Net) | $1M | $3M | $4M | $4M | $897.0K | $52.0K | $860.0K | |
| PP&E (Gross) | $3M | $5M | $5M | $4M | $960.0K | $77.0K | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $403.0K | $63.0K | $25.0K | $1M | |
| Other Non-current Assets | $4M | $7M | $15M | $15M | $12M | $10.0K | $7.0K | |
| Total Assets | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Accounts Payable | $5M | $4M | $9M | $8M | $4M | $4.0K | $4M | |
| Current Liabilities | $25M | $18M | $36M | $28M | $15M | $6M | $5M | |
| Capital Leases | $3M | $3M | $4M | $5M | $2M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $5M | $2M | $5.0K | $547.0K | |
| Total Liabilities | $33M | $34M | $53M | $43M | $17M | $6M | $11M | |
| Long-term Debt | $10M | $11M | $11M | $11M | · | · | · | |
| Total Debt | $10M | $10M | $10M | $9M | · | · | · | |
| Common Stock | $54.0K | $53.0K | $50.0K | $41.0K | $41.0K | $40.0K | $3.0K | |
| Retained Earnings | $-723M | $-621M | $-486M | $-325M | $-202M | $-119M | $-73M | |
| AOCI | $28.0K | $275.0K | $256.0K | $-845.0K | · | · | · | |
| Stockholders' Equity | $26M | $114M | $190M | $263M | $363M | $430M | $-71M | |
| Liabilities + Equity | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Shares Outstanding | 54,388,022 | 53,052,912 | 49,951,989 | 40,861,386 | 40,587,067 | 39,844,522 | 3,166,946 |
التدفق النقدي 12
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $706.0K | $872.0K | $836.0K | $342.0K | $51.0K | $202.0K | $429.0K | |
| Stock-based Comp | $13M | $27M | $26M | $24M | $14M | $5M | $297.0K | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $4M | $-15M | $3M | $10M | $1M | $2M | · | |
| Operating Cash Flow | $-84M | $-122M | $-130M | $-89M | $-68M | $-38M | $-14M | |
| CapEx | $212.0K | $447.0K | $1M | $1M | $666.0K | $31.0K | $353.0K | |
| Investing Cash Flow | $83M | $86M | $45M | $-235M | $-5M | $610.0K | $-353.0K | |
| Stock Issued | $2M | $30M | · | · | · | $368M | · | |
| Net Stock Activity | $2M | $30M | · | · | · | $368M | · | |
| Financing Cash Flow | $362.0K | $31M | $59M | $10M | $2M | $463M | $15M | |
| Free Cash Flow | $-84M | $-122M | $-132M | $-91M | $-69M | $-38M | · | |
| Levered FCF | $-86M | · | · | · | · | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -3694.0% | · | |
| Net Margin | · | · | · | · | · | -3869.7% | · | |
| Pretax Margin | · | · | · | · | · | -3849.3% | · | |
| EBITDA Margin | · | · | · | · | · | -3676.9% | · | |
| ROA | -98.3% | -69.1% | -58.6% | -36.0% | -20.4% | -20.5% | · | |
| ROE | -225.0% | -107.7% | -89.7% | -44.9% | -22.3% | -13.4% | · | |
| ROIC | -291.1% | · | · | -46.7% | -23.0% | -10.2% | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 | 70.3 | · | |
| Quick Ratio | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 | 70.0 | · | |
| Debt / Equity | 0.4 | 0.1 | 0.1 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.2 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Interest Coverage | -64.9 | -82.4 | -108.8 | · | · | · | · |
الكفاءة 1
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | 0.0 | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | $4M | $0 | $0 | $1M | · | |
| Net Income TTM | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | · | |
| Market Cap | $61M | $89M | $744M | $461M | $872M | $3.43B | · | |
| Enterprise Value | $26M | $-29M | $571M | $204M | · | · | · | |
| P/E | -0.6 | -0.6 | -4.0 | -3.7 | -10.4 | -31.2 | · | |
| P/S | 16.5 | 23.7 | 199.2 | · | · | 2905.8 | · | |
| P/B | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Tangible Book | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Cash Flow | -0.7 | -0.7 | -5.7 | -5.2 | -12.8 | -89.7 | · | |
| P / FCF | -0.7 | -0.7 | -5.7 | -5.1 | -12.7 | -89.6 | · | |
| EV / EBITDA | -0.3 | 0.2 | -3.4 | -1.6 | · | · | · | |
| EV / FCF | -0.3 | 0.2 | -4.3 | -2.2 | · | · | · | |
| EV / Revenue | 7.1 | -7.8 | 152.9 | · | · | · | · | |
| Earnings Yield | -168.1% | -154.5% | -25.1% | -26.9% | -9.6% | -3.2% | · |
قائمة الدخل 13
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $18M | $17M | $18M | $24M | $24M | $26M | $35M | $32M | $42M | $46M | $29M | $25M | $25M | $29M | $27M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $8M | $7M | $6M | $7M | $6M | $6M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Operating Expenses | $19M | $23M | $23M | $27M | $32M | $31M | $33M | $42M | $38M | $48M | $53M | $37M | $32M | $32M | $37M | $34M | |
| Operating Income | $-19M | $-23M | $-23M | $-27M | $-32M | $-31M | $-33M | $-42M | $-38M | $-48M | $-53M | $-37M | $-32M | $-32M | $-37M | $-34M | |
| Interest Expense | $331.0K | $383.0K | $408.0K | $405.0K | $406.0K | $427.0K | $446.0K | $429.0K | $427.0K | $415.0K | $391.0K | $372.0K | $387.0K | $231.0K | $2.0K | $2.0K | |
| Interest Income | $1M | $573.0K | $802.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $876.0K | |
| Other Non-op | $188.0K | $-17.0K | $-6.0K | $-2.0K | $-11.0K | $-1.0K | $3.0K | $-8.0K | $-14.0K | $-29.0K | $-1.0K | $324.0K | $95.0K | $-2.0K | $-7.0K | $-5.0K | |
| Net Income | $-18M | $-23M | $-22M | $-26M | $-31M | $-29M | $-31M | $-39M | $-36M | $-45M | $-51M | $-34M | $-30M | $-31M | $-35M | $-33M | |
| EPS (Basic) | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-0.92 | $-1.24 | $-0.84 | $-0.74 | $-0.75 | $-0.87 | $-0.81 | |
| EPS (Diluted) | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-0.92 | $-1.24 | $-0.84 | $-0.74 | $-0.75 | $-0.87 | $-0.81 | |
| Shares (Basic) | 104,573,657 | -106,723,636 | 53,577,066 | 53,445,631 | 53,359,338 | -102,470,889 | 52,693,878 | 51,831,157 | 50,120,758 | -79,898,141 | 41,147,938 | 40,875,457 | 40,862,513 | -81,351,467 | 40,747,026 | 40,687,751 | |
| Shares (Diluted) | 104,573,657 | -106,723,636 | 53,577,066 | 53,445,631 | 53,359,338 | -102,470,889 | 52,693,878 | 51,831,157 | 50,120,758 | -79,898,141 | 41,147,938 | 40,875,457 | 40,862,513 | -81,351,467 | 40,747,026 | 40,687,751 | |
| EBITDA | $-19M | · | $-23M | $-27M | $-32M | · | $-33M | $-42M | $-38M | · | $-53M | $-37M | $-32M | · | $-37M | $-34M |
الميزانية العمومية 23
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $16M | $23M | $19M | $21M | $18M | $16M | $16M | $14M | $22M | $20M | $38M | $63M | $49M | $49M | $66M | |
| Short-term Investments | $108M | $28M | $37M | $60M | $77M | $110M | $132M | $141M | $143M | · | $170M | $175M | $165M | · | $236M | $247M | |
| Prepaid Expense | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $12M | $10M | · | $9M | $7M | $5M | · | $6M | $3M | |
| Other Current Assets | $25.0K | $20.0K | · | $4.0K | · | $27.0K | $1M | $315.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $146M | $51M | $67M | $85M | $103M | $134M | $156M | $169M | $168M | · | $199M | $220M | $233M | · | $291M | $317M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $2M | $2M | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $3M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $823.0K | $616.0K | · | $300.0K | $205.0K | |
| Other Non-current Assets | $3M | $4M | $9M | $4M | $7M | $7M | $13M | $13M | $14M | · | $11M | $11M | $13M | · | $16M | $17M | |
| Total Assets | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | · | $220M | $246M | $278M | · | $318M | $346M | |
| Accounts Payable | $4M | $5M | $7M | $5M | $4M | $4M | $8M | $8M | $6M | · | $13M | $4M | $10M | · | $6M | $9M | |
| Current Liabilities | $20M | $25M | $28M | $19M | $19M | $18M | $32M | $38M | $32M | · | $35M | $18M | $22M | · | $25M | $24M | |
| Capital Leases | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | $6M | |
| Other Non-current Liabilities | $4M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | · | $7M | $6M | $6M | · | $5M | $6M | |
| Total Liabilities | $27M | $33M | $38M | $31M | $33M | $34M | $49M | $55M | $48M | · | $51M | $33M | $38M | · | $31M | $30M | |
| Long-term Debt | $9M | $10M | $11M | $11M | $11M | $10M | $11M | $11M | $11M | · | $11M | $11M | $11M | · | · | · | |
| Total Debt | $9M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | · | $10M | $10M | $9M | · | · | · | |
| Common Stock | $135.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $52.0K | $50.0K | · | $41.0K | $41.0K | $41.0K | · | $41.0K | $41.0K | |
| Retained Earnings | $-741M | $-723M | $-700M | $-678M | $-652M | $-621M | $-592M | $-561M | $-522M | · | $-441M | $-390M | $-356M | · | $-295M | $-259M | |
| AOCI | $-245.0K | $28.0K | $43.0K | $36.0K | $118.0K | $275.0K | $563.0K | $-73.0K | $28.0K | · | $-226.0K | $-312.0K | $-88.0K | · | $-2M | $-1M | |
| Stockholders' Equity | $151M | $26M | $45M | $64M | $88M | $114M | $137M | $159M | $164M | $190M | $169M | $213M | $240M | $263M | $287M | $316M | |
| Liabilities + Equity | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | · | $220M | $246M | $278M | · | $318M | $346M | |
| Shares Outstanding | 134,540,741 | 54,388,022 | 53,577,566 | 53,506,777 | 53,384,145 | 53,052,912 | 52,743,104 | 52,452,749 | 50,277,193 | · | 41,151,819 | 40,992,179 | 40,863,049 | · | 40,748,290 | 40,745,252 |
التدفق النقدي 10
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $150.0K | $151.0K | $153.0K | $191.0K | $211.0K | $214.0K | $224.0K | $220.0K | $214.0K | $207.0K | $209.0K | $207.0K | $213.0K | $105.0K | $95.0K | $84.0K | |
| Stock-based Comp | $3M | $3M | $3M | $2M | $5M | $6M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | |
| Other Non-cash | $-3M | · | · | · | $664.0K | · | · | · | $-10M | · | · | · | $-4M | · | · | · | |
| Operating Cash Flow | $-19M | $-19M | $-17M | $-23M | $-25M | $-32M | $-25M | $-27M | $-38M | $-40M | $-31M | $-32M | $-28M | $-21M | $-31M | $-17M | |
| CapEx | $50.0K | $49.0K | $56.0K | $47.0K | $60.0K | $60.0K | $149.0K | $90.0K | $148.0K | $148.0K | $-1M | $2M | $690.0K | $389.0K | $192.0K | $257.0K | |
| Investing Cash Flow | $-105M | $11M | $21M | $22M | $28M | $33M | $26M | $907.0K | $26M | $-17M | $13M | $6M | $42M | $11M | $14M | $-76M | |
| Stock Issued | $11.0K | $1M | $0 | $0 | $372.0K | $359.0K | $75.0K | $26M | $3M | · | · | · | · | · | · | · | |
| Net Stock Activity | $11.0K | · | · | · | $372.0K | · | · | · | $3M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $140M | $678.0K | $-159.0K | $-222.0K | $65.0K | $328.0K | $251.0K | $27M | $3M | $59M | $-111.0K | $343.0K | $-107.0K | $9M | $-136.0K | $422.0K | |
| Free Cash Flow | $-19M | · | · | · | $-25M | · | · | · | $-38M | · | · | · | $-29M | · | · | · |
الربحية 2
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.0% | · | -16.5% | -16.7% | -18.4% | · | -15.1% | -17.1% | -14.5% | · | -19.0% | -11.5% | -9.4% | · | -9.8% | -8.6% | |
| ROE | -15.0% | · | -24.4% | -23.2% | -24.4% | · | -20.1% | -21.2% | -17.6% | · | -22.4% | -12.9% | -10.3% | · | -10.5% | -9.1% |
السيولة والملاءة 5
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.2 | · | 2.4 | 4.5 | 5.5 | · | 4.8 | 4.4 | 5.2 | · | 5.7 | 12.5 | 10.6 | · | 11.5 | 13.2 | |
| Quick Ratio | 7.0 | · | 2.2 | 4.2 | 5.2 | · | 4.6 | 4.1 | 4.9 | · | 5.4 | 12.1 | 10.4 | · | 11.3 | 13.1 | |
| Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | |
| Interest Coverage | -57.3 | · | -55.2 | -65.8 | -78.4 | · | -73.0 | -96.8 | -88.4 | · | -136.3 | -98.9 | -83.2 | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | |
| Net Income TTM | $-97M | · | $-110M | $-127M | $-136M | · | $-157M | $-160M | $-151M | · | $-151M | $-133M | $-123M | · | $-117M | $-98M | |
| Market Cap | $270M | · | $98M | $22M | $33M | · | $96M | $316M | $561M | · | $198M | $308M | $185M | · | $390M | $330M | |
| Enterprise Value | $138M | · | $48M | $-47M | $-55M | · | $-43M | $169M | $413M | · | $17M | $105M | $-34M | · | · | · | |
| P/E | -1.2 | · | -0.9 | -0.2 | -0.2 | · | -0.6 | -1.7 | -3.2 | · | -1.3 | -2.3 | -1.5 | · | -3.3 | -3.3 | |
| P/S | 72.3 | · | 26.3 | 5.9 | 8.9 | · | 25.7 | 84.7 | 150.2 | · | 52.9 | 82.5 | 49.5 | · | 104.5 | 88.3 | |
| P/B | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | · | 1.2 | 1.4 | 0.8 | · | 1.4 | 1.0 | |
| P / Tangible Book | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | · | 1.2 | 1.4 | 0.8 | · | 1.4 | 1.0 | |
| P / Cash Flow | -14.5 | · | · | · | -1.3 | · | · | · | -14.8 | · | · | · | -6.6 | · | · | · | |
| P / FCF | -14.4 | · | · | · | -1.3 | · | · | · | -14.7 | · | · | · | -6.5 | · | · | · | |
| EV / EBITDA | -7.3 | · | -2.1 | 1.8 | 1.7 | · | 1.3 | -4.1 | -11.0 | · | -0.3 | -2.8 | 1.1 | · | · | · | |
| EV / FCF | -7.4 | · | · | · | 2.2 | · | · | · | -10.8 | · | · | · | 1.2 | · | · | · | |
| EV / Revenue | 37.0 | · | 12.7 | -12.6 | -14.6 | · | -11.5 | 45.4 | 110.6 | · | 4.6 | 28.0 | -9.1 | · | · | · | |
| Earnings Yield | -82.3% | · | -112.6% | -580.7% | -422.1% | · | -180.8% | -58.9% | -31.7% | · | -76.9% | -43.4% | -66.8% | · | -30.2% | -29.9% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | — | — | — | $0 | $0 |
| صافي الدخل | $-102M | $-135M | $-161M | $-123M | $-83M |
| EPS المخفف | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.4 | 0.1 | 0.1 | 0.0 | — |
| النسبة الحالية | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 |
| النسبة السريعة | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-84M | $-122M | $-132M | $-91M | $-69M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.